Biology subjects

Lucey, B. P.

Publications and source records attributed to Lucey, B. P..

4 recordsLinked to original sources

bioRxiv2026

Quantitative Modelling of Amyloid-β Dynamics in Brain, CSF, and Plasma During Sleep and Wakefulness

Amyloid-beta (A{beta}) accumulation in the brain is linked to Alzheimer's disease. In healthy individuals, A{beta} rises during wakefulness and is cleared during sleep, yet the effects of sleep disturbances on the A{beta} dynamics are unclear. We developed a model, incorporating brain, cerebrospinal fluid (CSF), and plasma, to investigate the A{beta} dynamics along the sleep-wake cycles. The model reproduces the experimentally observed 24-hour A{beta}42 oscillations in CSF (660-760 pg/mL) and plasma (15-19 pg/mL) and predicts brain A{beta} dynamics. Indwelling lumbar catheter data show elevated CSF A{beta}42 levels on the second morning after a full night of sleep compared to first morning. The model predicts this increased level is due to repeated CSF sampling, which affects A{beta} levels through pressure-mediated changes in CSF, impaired sleep associated clearance, or their synergistic effect. These findings provide a framework for understanding A{beta} regulation, highlighting sleep's protective role and the need for non-invasive measurement approaches.

neuroscience↗

bioRxiv2026

Cross-Species Translation Enhances the Use of Mouse Models for Translatability and Drug Discovery in Late-Onset Alzheimer's Disease

Alzheimers disease (AD) is a brain disease characterized by deposition of insoluble amyloid-{beta} plaque, intraneuronal neurofibrillary tangles, and cognitive dysfunction. AD can be characterized as early-onset or late-onset based on age and genetic factors. For early-onset, these genetic factors can include amyloid precursor protein (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2). For late-onset, these can include apolipoprotein E e4 (APOE4), and the R47H variant of triggering receptor expressed on myeloid cells 2 (TREM2). Mouse models incorporating these risk factors provide critical knowledge for studying AD pathology and preclinical studies for drug development. However, these transgenic mice depend on early-onset genetic mutations and are deficient in certain AD features that are present in late-onset. Here, we developed innovative non-linear and feature selection procedures for our cross-species translation framework, Translatable Components Regression (TransComp-R), to identify transcriptomic features in mouse models predictive of human late-onset AD pathobiology. We used the cross-species computational translatability links of TransComp-R to perform computational high-throughput drug screening and identified multiple repurposable drugs for AD treatment that targeted the sleep-wake cycle. We tested these predictions in an orthogonal, prospective cohort of human subjects treated with an orexin receptor antagonist, suvorexant. We correlated conserved protein-level biomarkers from our cross-species transcriptomics model with significant reductions in phosphorylated tau in cerebrospinal fluid collected from humans treated with suvorexant. This study demonstrates the power of computational methods like TransComp-R to enhance the utility of murine disease models for discovering new therapeutic approaches for AD. One Sentence SummaryCross-species translation modeling across different mouse models reveals sleep-relevant drug mechanisms as potentially therapeutic for Alzheimers disease.

systems biology↗

bioRxiv2024

On Monitoring Brain Health from the Depths of Sleep: Feature Engineering and Machine Learning Insights for Digital Biomarker Development

BackgrounSingle-channel sleep electroencephalography (EEG) is a promising technology for creating cost-effective and widely accessible digital biomarkers for monitoring brain health. Sleep, notable for its numerous connections to brain health, is of particular interest in this context. Indeed, several of the best studied and widely recognized risk factors for neurodegenerative disease are also connected to aspects of sleep physiology, including biological sex, hypertension, diabetes, obesity/metabolic dysregulation, and immune system dysfunction. In this study, we utilize the unique signal characteristics of slow wave sleep (SWS) oscillatory events as features in machine learning models to predict underlying biological processes that are highly relevant to brain health. Our objective is to establish a foundation for algorithms capable of effectively monitoring physiological processes in sleep that directly and indirectly inform brain health using single-channel sleep EEG as a functional metric of brain activity. MethodsUtilizing data from the Cleveland Family Study, we analyzed 726 overnight polysomnography recordings to extract features from slow waves and adjacent oscillatory events. Advanced signal processing and machine learning techniques, including random forest models, were employed to engineer features and predict health-related outcomes such as age, cerebrovascular risk factors, endocrine functions, immune system activity, and sleep apnea. ResultsOur models demonstrated significant predictive capability for several outcomes, including age (R2 = 0.643, p < 0.001), and sex classification (area under the receiver operator characteristic (AUROC) curve = 0.808), diabetes and hypertension diagnosis (AUROC = 0.832 and 0.755, respectively). Significant predictions were also modeled for metabolic/endocrine functions (including blood concentrations of IGF-1, leptin, ghrelin, adiponectin, and glucose), and immune markers (including IL-6, TNF-alpha, and CRP). In addition, this approach provided successful predictions in regression modeling of BMI and both regression and classification of sleep apnea. DiscussionThis study demonstrates the potential of using features from oscillatory events in single-channel sleep EEG as digital biomarkers. These biomarkers can identify key health and demographic factors that both affect brain health and are indicative of core brain functions. By capturing the complex interactions of neural, metabolic, endocrine, and immune systems during sleep, our findings support the development of single-channel EEG as a practical tool for monitoring complex biological processes through metrics that originate in brain physiology. Future research should aim to refine these digital biomarkers for broader home-based applications that may utilize inexpensive "wearable" devices to provide a scalable and accessible tool for tracking brain health-related outcomes.

neuroscience↗

bioRxiv2023

Mapping Sleep's Oscillatory Events as a Biomarker of Alzheimer's Disease

ObjectiveMemory-associated neural circuits produce oscillatory events within single-channel sleep electroencephalography (EEG), including theta bursts (TBs), sleep spindles (SPs) and multiple subtypes of slow waves (SWs). Changes in the temporal "coupling" of these events are proposed to serve as a biomarker for early stages of Alzheimers disease (AD) pathogenesis. MethodsWe analyzed data from 205 aging adults, including single-channel sleep EEG, cerebrospinal fluid (CSF) AD-associated biomarkers, and Clinical Dementia Rating(R) (CDR(R)) scale. Individual SW events were sorted into high and low transition frequencies (TF) subtypes. We utilized time-frequency spectrogram locations within sleep EEG to "map" the precision of SW-TB and SW-SP neural circuit coupling in relation to amyloid positivity (by CSF A{beta}42/A{beta}40 threshold), cognitive impairment (by CDR), and CSF levels of AD-associated biomarkers. ResultsCognitive impairment was associated with lower TB spectral power in both high and low TF SW-TB coupling (p<0.001, p=0.001). Cognitively unimpaired, amyloid positive aging adults demonstrated lower precision of the neural circuits propagating high TF SW-TB (p<0.05) and low TF SW-SP (p<0.005) event coupling, compared to cognitively unimpaired amyloid negative individuals. Biomarker correlations were significant for high TF SW-TB coupling with CSF A{beta}42/A{beta}40 (p=0.005), phosphorylated-tau181 (p<0.005), and total-tau (p<0.05). Low TF SW-SP coupling was also correlated with CSF A{beta}42/A{beta}40 (p<0.01). InterpretationLoss of integrity in neural circuits underlying sleep-dependent memory processing can be measured for both SW-TB and SW-SP coupling in spectral time-frequency space. Breakdown of sleeps memory circuit integrity is associated with amyloid positivity, higher levels of AD-associated pathology, and cognitive impairment.

neuroscience↗